Magenta fentanyl strip vs multi-panel cup with fentanyl

The standalone strip is the right format in two main contexts. The first is supplementing an existing screening workflow. If you already buy 5-panel or 10-panel cups in volume and you do not want to swap the whole inventory over to a fentanyl-inclusive cup, adding a separate fentanyl strip lets you keep your primary panel and bolt fentanyl detection on as a second device. This is common in employer programs and DOT-adjacent testing where the primary panel is locked by policy or by a TPA's approved device list.

The second is harm-reduction outreach. Community-health programs, syringe-service programs, and substance-use response programs increasingly distribute fentanyl test strips as part of overdose-prevention outreach. The strip format fits a backpack, costs little per unit, and the single-analyte test communicates a single clear signal. Programs in this space should follow guidance from their state health department and SAMHSA's harm-reduction grant program on storage, distribution, and counseling protocols.

The strip is also the right choice for programs piloting fentanyl detection before committing budget to a full panel upgrade. Running a few months of strip-paired-with-existing-cup gives you positivity data for your specific population that can inform whether moving the whole inventory to a fentanyl-inclusive cup is justified.

The limit is workflow overhead. A second device adds a second read, a second documentation step, and a second SKU to manage in inventory. For any program where fentanyl screening is part of the primary clinical workflow rather than a supplement, the integrated multi-panel cup is operationally simpler.

Integrated multi-panel cups with fentanyl are the right format when fentanyl is part of the primary clinical screen rather than a supplemental add-on. For addiction medicine, MAT clinics, sober-living programs, and post-overdose follow-up, fentanyl is not a special-case analyte — it is one of the most important analytes in the panel, alongside opiates and benzodiazepines, and the program runs it on every collection.

For that workflow, a single integrated device beats a two-device approach on every operational axis. One collection, one read, one chain-of-custody event, one SKU in inventory, one line item on the patient's chart. The per-test cost premium over a standard 12-panel without fentanyl is small relative to the operational simplicity of running everything through one device.

The 13-panel adds fentanyl to the standard 12-panel scope. The 14-panel adds both fentanyl and ETg (ethyl glucuronide), which extends the alcohol-detection window to roughly 1 to 3 days after last drink (substantially longer than breath or blood alcohol's few-hour window). For sober-living programs, court-ordered abstinence monitoring, and any program where alcohol abstinence matters as much as drug abstinence, the 14-panel + ETg is the right configuration.

The 14-panel + adulterants configuration adds the same three specimen-validity strips (creatinine, pH, oxidants / specific gravity) discussed elsewhere in our catalog. Programs with motivated-donor populations who also need fentanyl detection should look at this configuration directly.